Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
In one single-center trial of 72 subjects using a controlled-adverse-environment model, the T4 eye drop did not meet its co-primary endpoints (ocular discomfort and inferior corneal staining) at the primary time point, but it did produce statistically significant improvements on several secondary endpoints, including central and superior corneal staining, with no adverse events reported
The principle is straightforward: your body does not age, recover, or perform through a single mechanism
Yang SH, Cheng PH, Banta H, Piotrowska-Nitsche K, Yang JJ, Cheng EC, et al
Safety and proof of principle study of cerebellar vermal theta burst stimulation in refractory schizophrenia
Delivers active peptides over 68 hours, ensuring consistent recovery support where its needed most
Complete guidance on optimal capsule administration timing, food interactions, storage requirements, and integration with existing supplements or medications
US$ 20.93
US$ 20.89
US$ 27.33
US$ 20.78
US$ 20.86
US$ 22.01
US$ 26.92
